Clinical Trial Update: Study of the Clinical Management of Bipolar Disease

View source ↗

Summary

AstraZeneca's clinical trial on the clinical management of bipolar disorder has completed, according to the ClinicalTrials.gov update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorders | Status: COMPLETED